TY  - GEN
AU  - Yeni,P
AU  - Lamarca,A
AU  - Berger,D
AU  - Cimoch,P
AU  - Lazzarin,A
AU  - Salvato,P
AU  - Smaill,F M
AU  - Teofilo,E
AU  - Madison,S J
AU  - Nichols,W G
AU  - Adkison,K K
AU  - Bonny,T
AU  - Millard,J
AU  - McCarty,D
TI  - Antiviral activity and safety of aplaviroc, a CCR5 antagonist, in combination with lopinavir/ritonavir in HIV-infected, therapy-naïve patients: results of the EPIC study (CCR100136)
SN  - 1468-1293
PY  - 2009///1207
KW  - Adult
KW  - Aged
KW  - Benzoates
KW  - pharmacokinetics
KW  - Diketopiperazines
KW  - Drug Administration Schedule
KW  - Drug Therapy, Combination
KW  - Female
KW  - HIV Infections
KW  - drug therapy
KW  - HIV Protease Inhibitors
KW  - HIV-1
KW  - immunology
KW  - Humans
KW  - Lopinavir
KW  - Male
KW  - Middle Aged
KW  - Piperazines
KW  - Pyrimidinones
KW  - RNA, Viral
KW  - Receptors, CCR5
KW  - therapeutic use
KW  - Ritonavir
KW  - Spiro Compounds
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1468-1293.2008.00660.x
ER  -